Company Filing History:
1 out of 4,816 
1 out of 832,891 Years Active: 2020-2024
Title: The Innovative Mind of Balik Dzhambazov: Pioneering Autoantigenic Peptides
Introduction
Balik Dzhambazov, an accomplished inventor based in Plovdiv, Bulgaria, has made significant contributions to the field of biomedicine through his inventive work on autoantigenic peptides. With two patents to his name, Dzhambazov continues to push the boundaries of innovation aimed at addressing inflammatory joint diseases.
Latest Patents
Dzhambazov's latest inventions focus on a compound comprising an autoantigenic peptide and a carrier with a Major Histocompatibility Complex (MHC) binding motif. The inventive concept encompasses a compound that includes (a) a peptide and (b) a carrier, where the peptide features a specific motif X-X-X-X-X-X-X, with at least one of the amino acid residues being glycosylated.
The compound is linked to a peptide binding protein, and the carrier incorporates an MHC binding motif associated with the peptide. This innovative work extends to pharmaceutical compositions that utilize the compound to treat diseases, particularly inflammatory joint diseases. Notably, the application highlights peptides derived from type II collagen, exemplified by sequences such as AGFKGEA, IAGFKGEQPKG, and AAAKAAA, with a preference for glycosylated hydroxylysine residues in these peptides.
Career Highlights
Throughout his career, Balik Dzhambazov has been associated with prominent research institutions, including the Fraunhofer Society for the Advancement of Applied Research, which underscores his commitment to innovation and collaboration in medicine and biotechnology.
Collaborations
Dzhambazov's work has seen him collaborate with esteemed colleagues such as Rikard Holmdahl and Jan Kihlberg. These partnerships not only enhance the breadth of his inventions but also illustrate the collaborative spirit that drives scientific progress.
Conclusion
Balik Dzhambazov is a noteworthy innovator whose contributions in the realm of autoantigenic peptides may pave the way for new therapeutic strategies in treating inflammatory diseases. His patents reflect a dedication to research and innovation, emphasizing the importance of collaborative efforts in advancing medical science.